Description
Insulin Novorapid Vial 10ml
NovoLog Vials, known as NovoRapid in Canada, is a Novo Nordisk product designed to manage diabetes in adults and children as young as one-year-old. The key ingredient, insulin aspart, acts quickly to counteract high blood sugar.
Administered subcutaneously, typical injection sites include the abdomen, thigh, upper arm, or buttock. For correct administration techniques, seek guidance from healthcare professionals or diabetes educators.
These vials are generally used before meals, but post-meal administration is also acceptable. To effectively manage Type 2 diabetes, a regimen often involves NovoLog combined with long-acting or intermediate insulin. Regular glucose monitoring is crucial to determine the appropriate dosage. Additionally, other insulins like Lantus and Tresiba might be integrated into your treatment plan by your doctor.
Dosage is typically determined by body weight, ranging from 0.5 to 1.0 units per kg per day. When paired with meals, the insulin mix may comprise 50-70% of NovoRapid, with the balance being long-acting or intermediate insulin.
For those seeking an automated approach, a pump system can be used to deliver a continuous flow of NovoLog Insulin either subcutaneously or intravenously under medical supervision.